ARTICLE | Clinical News
ENMD-2076 regulatory update
July 28, 2014 7:00 AM UTC
CASI (formerly EntreMed Inc.) said FDA granted Orphan Drug designation to ENMD-2076 to treat hepatocellular carcinoma (HCC). The inhibitor of aurora kinase A ( AURKA; Aurora-A) and multiple tyrosin...